Jr. Whetstine et al., Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: Detection of expressed protein in African-America, TOX APPL PH, 168(3), 2000, pp. 216-224
The flavin-containing monooxygenases (FMOs) are a family of xenobiotic-meta
bolizing enzymes that are expressed in a species- and tissue-specific manne
r. FMO2 expression has been observed in pulmonary tissue from several speci
es, but not human. Two human FMO2 point mutations have been reported: a cyt
osine to thymidine transition at position 1414 resulting in a premature sto
p codon and a thymidine insertion at position 1589 resulting in a frameshif
t. To define the frequency of these sequence variations and explore their s
ignificance, unrelated African-American, Caucasian, and Korean individuals
were genotyped. In the African-American population tested (n = 180), the 14
14C allele occurred at a 13% frequency; however, all of the tested Caucasia
ns (n = 52) and Koreans (n = 100) were homozygous for the 1414T allele. The
T1589 allele occurred at frequencies of 6.9 and 13.0% in African-Americans
(n = 175) and Caucasians (n = 23), respectively, and appears to segregate
with the 1414T allele. Thus, it would have no further impact on FMO2 activi
ty. Western blot analysis of pulmonary microsomes failed to detect immunore
active protein in 1414T homozygotes. A heterozygotic individual did exhibit
a single band of the expected size, but no detectable FMO activity in the
corresponding lung microsomes. Sequence analysis, however, was consistent w
ith the 1414C allele encoding an active FMO2 enzyme. FMO2 mRNA expression w
as observed in most individuals, but failed to correlate with genotype or p
rotein expression. In summary, functional FMO2 is expressed in only a small
percentage of the overall population. However, in certain ethnic groups, a
ctive pulmonary FMO2 enzyme will be present in a significant number of indi
viduals. (C) 2000 Academic Press.